Tim and Chris discuss an ongoing case, VANDA PHARMACEUTICALS v. United States, which highlights the potential trade secret misappropriation by an FDA official!! This is preceded by a quick discussion of the FTC decision to ban non-compete agreements. More on that topic next week!
Episode 12: Trade Secret Litigation Lightning Round
In this episode of the Reasonable Measures podcast, Tim and Chris discuss three notable trade secret cases from Latvia, China, and the United States. They explore the implications of whistleblower retaliation, the intersection of trade secrets and criminal law, and the complexities of ongoing litigation between IQVIA and Viva Systems. The conversation highlights the evolving landscape of trade secret protection and the legal challenges faced by companies and individuals.
Takeaways:
- A Latvian case highlights the risks of whistleblowing and LinkedIn posts.
- Courts may be sympathetic to employees in trade secret disputes.
- In China, trade secrets can lead to criminal charges and jail time.
- The IQVIA vs. Viva Systems case exemplifies messy legal battles.
- Specificity in identifying trade secrets is increasingly required by courts.
- Trade secrets are not just civil matters; they can involve criminal law.
- The discussion reflects on the global nature of trade secret issues.
- The importance of understanding trade secret laws in different jurisdictions.